中文|English
Sign Up
Shopping cart
Search

The CDE issued a notice to solicit public opinion on the 《Procedure for Review and Approval of Drug Listing Application Subject to Conditions (Draft for public review)》

Column：Industry News Time：2020-04-30
The CDE issued a notice to solicit public opinion on the 《Procedure for Review and Approval of Drug Listing Application Subject to Conditions (Draft for public review)》

2020年4月30日，国家药品监督管理局药品审评中心发布对《药品附条件批准上市申请审评审批工作程序（征求意见稿）》意见的通知，公示日期为：2020年4月30日~2020年5月30日。       反馈意见稿邮箱：ftjcx@cde.org.cn。

网址链接：http://www.cde.org.cn/news.do?method=viewInfoCommon&id=315047


Previous： The CDE issued a notice to solicit public opinion on the 《Clinical technical requirements for unlisted drugs in China 》
Next： The CDE issued a notice to solicit public opinion on the 《Communication Measures on Drug R&D and Technology Review (Draft for public review)》